newsfilter
← Latest News
Business Wire·

2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors

2seventy bio, Inc. (NASDAQ:TSVT), announced today that Eli Casdin, Chief Investment Officer, and Founder of Casdin Capital, and Charles Newton, Chief Financial Officer, Lyell Immunopharma, have been appointed as new